Skip to main content

Celiac Disease and Bone Health

  • Chapter
  • First Online:
Nutrition and Bone Health

Part of the book series: Nutrition and Health ((NH))

Abstract

Celiac disease is an autoimmune disorder with genetic and environmental components. The prevalence of the disease is about 1 % in many parts of the world. It is characterized by innate and adaptive immune responses that are primarily triggered by the ingestion of dietary gluten, resulting in inflammation, villous atrophy, and crypt hyperplasia in the small intestine. Genes that code for human leukocyte antigens (HLA) DQ2 and DQ8 are strongly associated with and confer susceptibility for celiac disease. In addition to the characteristic intestinal symptoms, celiac disease is associated with extra-intestinal complications, including those affecting skeletal health. Reduction in bone mineral density and increased risk of bone fracture, caused by malabsorption-related alteration of calcium metabolism and immune-mediated mechanisms, are frequently seen in patients with celiac disease. The diagnosis of celiac disease relies on serologic testing and intestinal biopsy. Bone density evaluation is recommended within 1 year of diagnosis and treatment. Gluten-free diet is the recommended treatment for celiac disease, usually resulting in the gradual recovery of intestinal mucosa, which leads to elimination of calcium and vitamin deficiencies and progression towards normalization of bone density. This chapter summarizes the currently available information regarding the prevalence, pathogenic mechanism, and treatment of celiac disease in the context of bone health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:613–21.

    Article  PubMed  Google Scholar 

  2. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005;142:289–98.

    Article  CAS  PubMed  Google Scholar 

  3. Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev. 2008;7:644–50.

    Article  CAS  PubMed  Google Scholar 

  4. Joplin GF, Melvin KE, Hepner GW, Neale G, Bordier P. Calcium metabolism and bone histology in adult celiac disease. Calcif Tissue Res. 1968;2(1 Suppl):62.

    Article  Google Scholar 

  5. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–44. quiz 1537, 1545.

    Article  PubMed  Google Scholar 

  6. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–8.

    Article  PubMed  Google Scholar 

  8. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95.

    Article  PubMed  Google Scholar 

  9. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens. 2003;61:105–17.

    Article  CAS  PubMed  Google Scholar 

  10. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007;39:827–9.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008;40:395–402.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193–201.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–43.

    Article  CAS  PubMed  Google Scholar 

  14. Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126–31.

    Article  PubMed  Google Scholar 

  15. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–92.

    Article  PubMed  Google Scholar 

  16. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun. 1999;13:143–8.

    Article  CAS  PubMed  Google Scholar 

  17. Lampasona V, Bonfanti R, Bazzigaluppi E, Venerando A, Chiumello G, et al. Antibodies to tissue transglutaminase C in type I diabetes. Diabetologia. 1999;42:1195–8.

    Article  CAS  PubMed  Google Scholar 

  18. Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23:464–83.

    Article  CAS  PubMed  Google Scholar 

  19. Mainardi E, Montanelli A, Dotti M, Nano R, Moscato G. Thyroid-related autoantibodies and celiac disease: a role for a gluten-free diet? J Clin Gastroenterol. 2002;35:245–8.

    Article  CAS  PubMed  Google Scholar 

  20. O’Leary C, Walsh CH, Wieneke P, O’Regan P, Buckley B, et al. Coeliac disease and autoimmune Addison’s disease: a clinical pitfall. QJM. 2002;95:79–82.

    Article  PubMed  Google Scholar 

  21. Rostami K, Steegers EA, Wong WY, Braat DD, Steegers-Theunissen RP. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol. 2001;96:146–9.

    Article  CAS  PubMed  Google Scholar 

  22. Meloni GF, Dessole S, Vargiu N, Tomasi PA, Musumeci S. The prevalence of coeliac disease in infertility. Hum Reprod. 1999;14:2759–61.

    Article  CAS  PubMed  Google Scholar 

  23. Corazza GR, Andreani ML, Venturo N, Bernardi M, Tosti A, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology. 1995;109:1333–7.

    Article  CAS  PubMed  Google Scholar 

  24. Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry. 1999;67:257.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 2001;49:540–3.

    Article  CAS  PubMed  Google Scholar 

  26. Shill HA, Alaedini A, Latov N, Hallett M. Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration. Neurology. 2003;60:1672–3.

    Article  PubMed  Google Scholar 

  27. Alaedini A, Green PH, Sander HW, Hays AP, Gamboa ET, et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol. 2002;127:145–8.

    Article  CAS  PubMed  Google Scholar 

  28. Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry. 2003;74:490–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Chin RL, Sander HW, Brannagan TH, Green PHR, Hays AP, et al. Celiac neuropathy. Neurology. 2003;60:1581–5.

    Article  CAS  PubMed  Google Scholar 

  30. Luostarinen L, Dastidar P, Collin P, Peraaho M, Maki M, et al. Association between coeliac disease, epilepsy and brain atrophy. Eur Neurol. 2001;46:187–91.

    Article  CAS  PubMed  Google Scholar 

  31. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, et al. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003;98:625–9.

    Article  PubMed  Google Scholar 

  32. Curione M, Barbato M, De Biase L, Viola F, Lo Russo L, et al. Prevalence of coeliac disease in idiopathic dilated cardiomyopathy. Lancet. 1999;354:222–3.

    Article  CAS  PubMed  Google Scholar 

  33. Frustaci A, Cuoco L, Chimenti C, Pieroni M, Fioravanti G, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.

    Article  PubMed  Google Scholar 

  34. Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol. 2000;14:672–5.

    CAS  PubMed  Google Scholar 

  35. Sjoberg K, Lindgren S, Eriksson S. Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease. Scand J Gastroenterol. 1997;32:1162–7.

    Article  CAS  PubMed  Google Scholar 

  36. Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.

    Article  CAS  PubMed  Google Scholar 

  37. Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002;87:293–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Ransford RA, Hayes M, Palmer M, Hall MJ. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol. 2002;35:228–33.

    Article  CAS  PubMed  Google Scholar 

  39. Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma VM, et al. Osteoporosis in adult patients with celiac disease. Bone. 1999;24:249–55.

    Article  CAS  PubMed  Google Scholar 

  40. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and “Club del Tenue” Working Groups on Coeliac Disease. Gut. 1998;42:362–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Iltanen S, Collin P, Korpela M, Holm K, Partanen J, et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren’s syndrome. Am J Gastroenterol. 1999;94:1042–6.

    CAS  PubMed  Google Scholar 

  42. Lepore L, Martelossi S, Pennesi M, Falcini F, Ermini ML, et al. Prevalence of celiac disease in patients with juvenile chronic arthritis. J Pediatr. 1996;129:311–3.

    Article  CAS  PubMed  Google Scholar 

  43. Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495–8.

    Article  CAS  PubMed  Google Scholar 

  44. Agardh D, Nilsson A, Carlsson A, Kockum I, Lernmark A, et al. Tissue transglutaminase autoantibodies and human leucocyte antigen in Down’s syndrome patients with coeliac disease. Acta Paediatr. 2002;91:34–8.

    Article  CAS  PubMed  Google Scholar 

  45. Ventura A, Martelossi S. Dental enamel defects and coeliac disease. Arch Dis Child. 1997;77:91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Aine L, Maki M, Collin P, Keyrilainen O. Dental enamel defects in celiac disease. J Oral Pathol Med. 1990;19:241–5.

    Article  CAS  PubMed  Google Scholar 

  47. Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395–8.

    Article  PubMed  Google Scholar 

  48. Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol. 2003;1:19–27.

    Article  PubMed  Google Scholar 

  49. Dupont FM, Vensel WH, Tanaka CK, Hurkman WJ, Altenbach SB. Deciphering the complexities of the wheat flour proteome using quantitative two-dimensional electrophoresis, three proteases and tandem mass spectrometry. Proteome Sci. 2011;9:10.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev. 2005;206:219–31.

    Article  PubMed  Google Scholar 

  51. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333–40.

    Article  CAS  PubMed  Google Scholar 

  52. Qiao SW, Iversen R, Raki M, Sollid LM. The adaptive immune response in celiac disease. Semin Immunopathol. 2012;34:523–40.

    Article  CAS  PubMed  Google Scholar 

  53. Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity. 2008;41:19–26.

    Article  CAS  PubMed  Google Scholar 

  54. Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:639–60.

    Article  PubMed  Google Scholar 

  55. Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209:2395–408.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795–841.

    Article  PubMed  Google Scholar 

  57. Fouda MA, Khan AA, Sultan MS, Rios LP, McAssey K, et al. Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol. 2012;26:819–29.

    PubMed Central  PubMed  Google Scholar 

  58. Vasquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol. 2000;95:183–9.

    Article  CAS  PubMed  Google Scholar 

  59. Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther. 2007;25:273–85.

    Article  CAS  PubMed  Google Scholar 

  60. Olmos M, Antelo M, Vazquez H, Smecuol E, Maurino E, et al. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis. 2008;40:46–53.

    Article  CAS  PubMed  Google Scholar 

  61. Barera G, Mora S, Brambilla P, Ricotti A, Menni L, et al. Body composition in children with celiac disease and the effects of a gluten-free diet: a prospective case-control study. Am J Clin Nutr. 2000;72:71–5.

    CAS  PubMed  Google Scholar 

  62. Sonti R, Lebwohl B, Lewis SK, Abu Daya H, Klavan H, et al. Men with celiac disease are shorter than their peers in the general population. Eur J Gastroenterol Hepatol. 2013;25(9):1033–7.

    Article  PubMed  Google Scholar 

  63. Street ME, Volta C, Ziveri MA, Zanacca C, Banchini G, et al. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol (Oxf). 2008;68:22–8.

    Article  CAS  Google Scholar 

  64. Federico G, Favilli T, Cinquanta L, Ughi C, Saggese G. Effect of celiac disease and gluten-free diet on growth hormone-binding protein, insulin-like growth factor-I, and insulin-like growth factor-binding proteins. Horm Res. 1997;48:108–14.

    Article  CAS  PubMed  Google Scholar 

  65. Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull. 2008;86:77–93.

    Article  PubMed  Google Scholar 

  66. Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys. 2010;503:54–65.

    Article  CAS  PubMed  Google Scholar 

  67. Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012;41:557–69.

    Article  CAS  PubMed  Google Scholar 

  68. Tavakkoli A, DiGiacomo D, Green PH, Lebwohl B. Vitamin D status and concomitant autoimmunity in celiac disease. J Clin Gastroenterol. 2013;47:515–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Fraser WD. Hyperparathyroidism. Lancet. 2009;374:145–58.

    Article  CAS  PubMed  Google Scholar 

  70. Pearson DA. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract. 2007;22:517–44.

    Article  PubMed  Google Scholar 

  71. Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228:1149–53.

    Article  CAS  PubMed  Google Scholar 

  72. Mager DR, Qiao J, Turner J. Vitamin D and K status influences bone mineral density and bone accrual in children and adolescents with celiac disease. Eur J Clin Nutr. 2012;66:488–95.

    Article  CAS  PubMed  Google Scholar 

  73. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr. 1999;69:354–65.

    CAS  PubMed  Google Scholar 

  74. Fornari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, et al. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol. 1998;93:413–8.

    Article  CAS  PubMed  Google Scholar 

  75. Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res. 2004;19:1112–21.

    Article  CAS  PubMed  Google Scholar 

  76. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15:2–12.

    Article  CAS  PubMed  Google Scholar 

  77. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.

    Article  CAS  PubMed  Google Scholar 

  78. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.

    Article  PubMed  Google Scholar 

  79. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888–94.

    Article  CAS  PubMed  Google Scholar 

  80. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.

    Article  PubMed  Google Scholar 

  81. Rashtak S, Ettore MW, Homburger HA, Murray JA. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2008;6:426–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  82. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–4.

    Article  PubMed  Google Scholar 

  83. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.

    CAS  PubMed  Google Scholar 

  84. Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S. Diagnosis of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:661–77.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Simpson S, Thompson T. Nutrition assessment in celiac disease. Gastrointest Endosc Clin N Am. 2012;22:797–809.

    Article  PubMed  Google Scholar 

  86. Lee SK, Lo W, Memeo L, Rotterdam H, Green PH. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc. 2003;57:187–91.

    Article  PubMed  Google Scholar 

  87. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008;6:314–20.

    Article  PubMed  Google Scholar 

  88. Corazza GR, Di Stefano M, Jorizzo RA, Cecchetti L, Minguzzi L, et al. Propeptide of type I procollagen is predictive of posttreatment bone mass gain in adult celiac disease. Gastroenterology. 1997;113:67–71.

    Article  CAS  PubMed  Google Scholar 

  89. Troncone R, Kosova R. Short stature and catch-up growth in celiac disease. J Pediatr Gastroenterol Nutr. 2010;51 Suppl 3:S137–8.

    Article  PubMed  Google Scholar 

  90. Lebwohl B, Michaelsson K, Green PH, Ludvigsson JF. Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab. 2014;99:609–16.

    Article  CAS  PubMed  Google Scholar 

  91. Pazianas M, Butcher GP, Subhani JM, Finch PJ, Ang L, et al. Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake. Osteoporos Int. 2005;16:56–63.

    Article  CAS  PubMed  Google Scholar 

  92. Thompson T. Gluten contamination of commercial oat products in the United States. N Engl J Med. 2004;351:2021–2.

    Article  CAS  PubMed  Google Scholar 

  93. Questions and answers: gluten-free food labeling final rule. U.S. Food and Drug Administration. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/Allergens/ucm362880.htm. 2014; Accessed 10/12/2014.

  94. Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med. 2011;269:604–13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Armin Alaedini Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Alaedini, A. (2015). Celiac Disease and Bone Health. In: Holick, M., Nieves, J. (eds) Nutrition and Bone Health. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2001-3_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2001-3_37

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2000-6

  • Online ISBN: 978-1-4939-2001-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics